Kevin T. Larkin
- Published in print:
- 2005
- Published Online:
- October 2013
- ISBN:
- 9780300106442
- eISBN:
- 9780300128864
- Item type:
- chapter
- Publisher:
- Yale University Press
- DOI:
- 10.12987/yale/9780300106442.003.0009
- Subject:
- Psychology, Health Psychology
This chapter focuses on the pharmacologic and non-pharmacologic treatment and prevention of hypertension. It first discusses some antihypertensive medications that could be prescribed to treat high ...
More
This chapter focuses on the pharmacologic and non-pharmacologic treatment and prevention of hypertension. It first discusses some antihypertensive medications that could be prescribed to treat high blood pressure. The classes of antihypertensive medications discussed are diuretics, adrenergic-inhibiting agents, and vasodilators. It then examines the effect of antihypertensive agents on cognitive functioning and cardiovascular reactivity to stress. Finally, the chapter explores a number of non-pharmacologic, psychological interventions that have been used with hypertensive patients.Less
This chapter focuses on the pharmacologic and non-pharmacologic treatment and prevention of hypertension. It first discusses some antihypertensive medications that could be prescribed to treat high blood pressure. The classes of antihypertensive medications discussed are diuretics, adrenergic-inhibiting agents, and vasodilators. It then examines the effect of antihypertensive agents on cognitive functioning and cardiovascular reactivity to stress. Finally, the chapter explores a number of non-pharmacologic, psychological interventions that have been used with hypertensive patients.
David Eidelberg
- Published in print:
- 2011
- Published Online:
- September 2011
- ISBN:
- 9780195393484
- eISBN:
- 9780199914494
- Item type:
- book
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/acprof:oso/9780195393484.001.0001
- Subject:
- Neuroscience, Disorders of the Nervous System, Techniques
This volume provides up-to-date information concerning new applications of brain imaging to the study of Parkinson’s disease (PD). The chapters, written by experts in this field, focus on the various ...
More
This volume provides up-to-date information concerning new applications of brain imaging to the study of Parkinson’s disease (PD). The chapters, written by experts in this field, focus on the various imaging methodologies that have recently been used to study the natural history of the disease with emphasis on each of the distinctive clinical features that characterize the disorder (e.g., bradykinesia, rigidity, tremor and gait disturbance). Individual chapters also address the role of imaging in differential diagnosis, and in the evaluation of cognitive dysfunction/dementia in parkinsonian patients. Considerable emphasis is placed on potential applications of neuroimaging in clinical trials to assess new pharmacologic and surgical treatment strategies for PD, including deep brain stimulation (DBS), cell transplantation, and gene therapy. In-depth discussion is provided on advanced imaging applications, including rest-state and activation fMRI, volumetric MR, PET assessment of dopaminergic and cholinergic neurotransmission, and echosonography. Additional topics cover recent developments in the use of brain imaging to assess disease mechanisms including neuroinflammation, protein aggregation, and disordered brain network organization in PD.Less
This volume provides up-to-date information concerning new applications of brain imaging to the study of Parkinson’s disease (PD). The chapters, written by experts in this field, focus on the various imaging methodologies that have recently been used to study the natural history of the disease with emphasis on each of the distinctive clinical features that characterize the disorder (e.g., bradykinesia, rigidity, tremor and gait disturbance). Individual chapters also address the role of imaging in differential diagnosis, and in the evaluation of cognitive dysfunction/dementia in parkinsonian patients. Considerable emphasis is placed on potential applications of neuroimaging in clinical trials to assess new pharmacologic and surgical treatment strategies for PD, including deep brain stimulation (DBS), cell transplantation, and gene therapy. In-depth discussion is provided on advanced imaging applications, including rest-state and activation fMRI, volumetric MR, PET assessment of dopaminergic and cholinergic neurotransmission, and echosonography. Additional topics cover recent developments in the use of brain imaging to assess disease mechanisms including neuroinflammation, protein aggregation, and disordered brain network organization in PD.
Vanila Singh and Rachel Katonak
- Published in print:
- 2019
- Published Online:
- October 2019
- ISBN:
- 9780190056810
- eISBN:
- 9780190056841
- Item type:
- chapter
- Publisher:
- Oxford University Press
- DOI:
- 10.1093/oso/9780190056810.003.0007
- Subject:
- Public Health and Epidemiology, Public Health
While public health practitioners generally focus on the primary prevention of illness and disease by developing programs and policies that promote health and well-being, an understanding of chronic ...
More
While public health practitioners generally focus on the primary prevention of illness and disease by developing programs and policies that promote health and well-being, an understanding of chronic pain and its treatment is important for public health professionals working to address the opioid crisis. There are unintended consequences of well-intentioned policies that may restrict prescribing behavior or otherwise interrupt or change access to opioids. For example, one consequence of expanding state prescription drug monitoring programs has been concern by providers that “legitimate” pain patients may be subjected to increased suspicion and stigma and not able to obtain needed medications. State and federal efforts to shut down “pill mills” are vital to addressing diversion and criminal behavior, but pain patients who are also seen in these clinics may have an interruption in their treatment or access to medication. Understanding chronic pain treatment and non-opioid alternatives to pain management is an important part of developing sound public health policies to prevent opioid use disorder and its sequelae. This chapter presents these alternatives and the evidence base for each.Less
While public health practitioners generally focus on the primary prevention of illness and disease by developing programs and policies that promote health and well-being, an understanding of chronic pain and its treatment is important for public health professionals working to address the opioid crisis. There are unintended consequences of well-intentioned policies that may restrict prescribing behavior or otherwise interrupt or change access to opioids. For example, one consequence of expanding state prescription drug monitoring programs has been concern by providers that “legitimate” pain patients may be subjected to increased suspicion and stigma and not able to obtain needed medications. State and federal efforts to shut down “pill mills” are vital to addressing diversion and criminal behavior, but pain patients who are also seen in these clinics may have an interruption in their treatment or access to medication. Understanding chronic pain treatment and non-opioid alternatives to pain management is an important part of developing sound public health policies to prevent opioid use disorder and its sequelae. This chapter presents these alternatives and the evidence base for each.
